Log in

NYSE:CO - Global Cord Blood Stock Price, Forecast & News

$5.00
0.00 (0.00 %)
(As of 01/22/2020 01:35 AM ET)
Today's Range
$4.90
Now: $5.00
$5.04
50-Day Range
$4.40
MA: $4.79
$5.22
52-Week Range
$4.14
Now: $5.00
$7.73
Volume87,065 shs
Average Volume63,097 shs
Market Capitalization$607.76 million
P/E Ratio11.11
Dividend YieldN/A
Beta0.14
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. Read More…

Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone852-3605-8180

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$147.03 million
Cash Flow$0.42 per share
Book Value$4.20 per share

Profitability

Net Income$43.38 million

Miscellaneous

Employees1,261
Market Cap$607.76 million
Next Earnings Date2/24/2020 (Estimated)
OptionableOptionable

Receive CO News and Ratings via Email

Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.


Global Cord Blood (NYSE:CO) Frequently Asked Questions

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Corp (NYSE:CO) announced its quarterly earnings data on Tuesday, November, 26th. The medical research company reported $0.14 earnings per share (EPS) for the quarter. The medical research company earned $43.86 million during the quarter. Global Cord Blood had a net margin of 34.86% and a return on equity of 10.88%. View Global Cord Blood's Earnings History.

When is Global Cord Blood's next earnings date?

Global Cord Blood is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Global Cord Blood.

Has Global Cord Blood been receiving favorable news coverage?

News stories about CO stock have trended somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Global Cord Blood earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Global Cord Blood.

Are investors shorting Global Cord Blood?

Global Cord Blood saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 57,300 shares, an increase of 38.1% from the December 15th total of 41,500 shares. Based on an average daily volume of 63,900 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.2% of the shares of the stock are short sold. View Global Cord Blood's Current Options Chain.

Who are some of Global Cord Blood's key competitors?

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include Fate Therapeutics (FATE), Spero Therapeutics (SPRO), AbbVie (ABBV), Rite Aid (RAD), NovaBay Pharmaceuticals (NBY), Galectin Therapeutics (GALT), Gilead Sciences (GILD), Intel (INTC), Marvell Technology Group (MRVL) and Vertex Pharmaceuticals (VRTX).

Who are Global Cord Blood's key executives?

Global Cord Blood's management team includes the folowing people:
  • Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 47)
  • Mr. Albert Chen, CFO & Director (Age 43)
  • Ms. Xin Xu, Chief Technology Officer (Age 65)
  • Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 60)
  • Ms. Cathy Bai, VP of Corp. Fin.

How do I buy shares of Global Cord Blood?

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $5.00.

How big of a company is Global Cord Blood?

Global Cord Blood has a market capitalization of $607.76 million and generates $147.03 million in revenue each year. Global Cord Blood employs 1,261 workers across the globe.View Additional Information About Global Cord Blood.

What is Global Cord Blood's official website?

The official website for Global Cord Blood is http://www.globalcordbloodcorp.com/.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]


MarketBeat Community Rating for Global Cord Blood (NYSE CO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  233 (Vote Outperform)
Underperform Votes:  227 (Vote Underperform)
Total Votes:  460
MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel